In the business world, Peter Drucker’s famous quote, “Culture eats strategy for breakfast,” highlights the idea that no matter how brilliant a strategy may be, the surrounding culture will ultimately dictate its success. This adage finds a parallel in the medical and healthcare fields, where I propose that “Context eats content for breakfast”.
In medicine, the most well-intentioned guidelines, data, or treatment protocols can be overwhelmed by the complexities of individual patient contexts. The intricate nature of healthcare decision-making transcends the one-size-fits-all standardised approach, forcing physicians to adapt to the multifaceted realities of clinical practice.
The Problem with Simplified Content in Healthcare
In the age of evidence-based medicine, physicians are bombarded with an ever-growing array of data, guidelines, clinical trial outcomes, and protocols aimed at standardising patient care. These resources, while useful, often distil the complexities of patient care into simplified checklists or flowcharts. This “content,” though scientifically and/or statistically sound, fails to address the myriad of contextual factors that shape a patient’s health in the real-world decisions physicians, in conjunction with patients must make.
Content-driven approaches, such as rigid adherence to treatment guidelines or following standardised regimens without modification, can create an illusion of certainty in a field where uncertainty reigns. They prioritize the “what” over the “why” and the “how,” assuming that all patients will respond similarly to a given treatment based on the data hierarchy Evidence-Based Medicine (EBM) pyramid which ironically places case-series and expert opinion at the bottom!
However, physicians know that content alone cannot substitute for the contextual elements that make each patient’s case unique and idiosyncratic. Social, psychological, financial, and environmental factors may also come into play when determining the best course of action for a patient. Ignoring context in favour of pure content may lead to misguided decisions, which may even ultimately adversely affect patient outcomes.
Healthcare Complexity: Context as the Deciding Factor
From a clinical perspective, physicians are often required to adapt textbook knowledge to the messy reality of clinical practice. What works in a highly-controlled trial with a carefully selected patient population may not work in the unpredictable conditions of a hospital or clinic, where patients present with multiple comorbidities, varying levels of adherence to treatment, concomitant treatments and unique preferences etc. This discrepancy requires physicians to not just follow content but to apply critical thinking and adapt treatment based on a broader clinical context.
For instance, a heart failure guideline may recommend a specific drug regimen, but what happens if the patient has kidney disease or cannot afford or have access to the medication? Adjusting for context means understanding not just what works in a general population, but what works for each and every patient.
Beyond clinical variables, patients themselves bring layers of complexity to the decision-making process. Their medical histories, cultural backgrounds, mental health, financial status, and personal values all influence what treatment options are viable. Physicians, in conjunction with patients must balance these individual factors with available evidence to deliver individualised care, a process that goes well beyond simply following published guidelines.
Imagine a scenario where a patient is prescribed a new drug based on the latest clinical data, yet the patient hesitates because of concerns about side effects they’ve heard about online. The physician must address not only the clinical data but also the patient’s fears and emotional concerns. In this case, the patient’s psychological context becomes just as important as the scientific content of the medication.
The broader healthcare ecosystem also shapes the decision-making process. Limited access to certain medications, administrative burdens, insurance restrictions, and resource limitations in underfunded hospitals or clinics all add layers of complexity. A physician may want to prescribe the most effective treatment based on the latest research, but if the patient’s insurance doesn’t cover it or the healthcare setting lacks the necessary infrastructure, alternative strategies must be considered.
In these scenarios, healthcare providers must make the best possible decisions within the constraints of the system, often modifying their ideal course of action to fit the context of what is available or feasible.
AI, Big Data, and the Complexity of Context
The advent of artificial intelligence (AI) and machine learning promises to revolutionise healthcare by helping physicians make sense of massive amounts of medical data and potentially help in predicting outcomes. AI tools, however, provide content – often in the form of predictive analytics or personalised treatment recommendations – but even these technologies cannot replace the importance of context.
No matter how advanced, AI cannot fully appreciate the complex human factors that a physician must consider: the mistrust a patient might have for certain treatments, the family dynamics influencing healthcare decisions, or the broader social determinants of health like poverty, housing instability, and lack of education.
Physicians must still take this AI-generated content and contextualise it to fit the particularities of the patient sitting before them. AI may suggest the most statistically successful treatment path, but it cannot sense the subtleties of a patient’s fear, their religious beliefs, or their ability to comply with complex treatment regimens. In this way, context still reigns supreme over content, even in an era of advanced technology due to the omnipresent uncertainties.
The Physician’s Role: Mediator of Context and Content
In light of these challenges, the role of the physician is becoming increasingly complex. Far from simply being a conduit of medical knowledge, physicians are now required to be mediators who can blend scientific content with the ever-changing and unique contexts of their patients.
They must navigate a sea of clinical data, guidelines, experience and protocols while continuously filtering this information through the lens of patient-specific factors. The physician’s judgement, honed through experience and knowledge of their patients, is crucial in adapting generalised medical content to the specific and often messy realities of clinical practice.
Moreover, this complexity in decision-making is only likely to increase as medical content becomes even more granular with advancements in genomics, personalized medicine, and AI. As these new tools emerge, they will further enhance the physician’s ability to fine-tune treatments, but the importance of context will not diminish.
Conclusion
As healthcare becomes more data-driven, it is easy to believe that “better” content – whether it be through advanced algorithms, comprehensive guidelines, or evidence-based protocols—will lead to better decisions. However, the truth is that context eats content for breakfast in healthcare, just as culture overpowers strategy in business.
The complexity of medical decision-making demands more than just adherence to content; it requires an understanding of the many contextual layers that make each patient’s case unique. Physicians must embrace this complexity and learn to blend data with the realities of their patients’ lives, ensuring that the best decisions are made not just for the “average” patient, but for the individual standing in front of them.
This article represents an offshoot of some research I am conducting with Professor Piotr Trapczynski (Poznan University of Economics & Business, Poland) with some writing support from ChatGPT4o.
About the authors:
Richard Evans MBA, MSc
Richard is a former NHS (UK) Biomedical Scientist with specialist training in haematology, immunology and clinical biochemistry where he led the setup and development of special haematology diagnostic techniques for haematology, haemoncology, haemostasis and transfusion medicine science, over a period of 10 years where he was also an active participant in the out of hours emergency haematology team for transfusions, major incidents, coagulopathies etc. He also taught haematology for physicians in preparation for their MRCP Part 2 examination and biomedical scientists for their state-registration examinations as well as delivering lectures on monoclonal antibody production, general immunology and fluorescence-activated cell sorting techniques.
He has been in Commercial and Medical Affairs roles in pharma/biotech for over 20 years in roles as both individual contributor (commercial manager, MSL etc) and team leader (MSL manager, International MSL Director, Regional Medical Manager, Associate Medical Director, European Medical Director and European Brand Director) across many therapeutic areas.
Academically, more recently he also has 12 years experience as a University External Examiner in Human Resource Management MSc courses at University of Wales (4 years) and as External Examiner in Regulatory Affairs (Pharmaceuticals and Medical Devices) for TOPRA at University of Herts (5 years) and also as External Examiner in Regulatory Affairs Science MSc (3 years) also at University of Herts. Current research interests are focused on V2-vasopressin receptor pathways and targeted antitumour mechanistics as well as tumour macroenvironment and contextual intelligence in volatile, uncertain, complex and ambiguous (VUCA) decision-making scenarios.
Piotr Trąpczyński, PhD, D.Sc.
Professor of International Business, Director of the Institute of International Business and Economics at the Poznań University of Economics and Business
Piotr is a senior scholar with more than 15 years of experience in academic and applied research in the area of firm internationalisation strategies, international market analysis and performance outcomes of international expansion. His research was published in such outlets as the Journal of World Business, Journal of Business Research, International Business Review or European Management Journal. He shares the results of his work within various educational activities, including Executive MBA and Executive DBA programmes, as well as international Master curricula. He is an experienced business consultant and strategist for SMEs and MNEs doing international business, supporting them with international market analysis, strategic planning, business plan creation and foreign network development.
Have an opinion on this article? Send a message to the editor.